SLC38A2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.993600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.881400E-01
Normal-vs-Stage2
9.928200E-01
Normal-vs-Stage3
9.235800E-02
Normal-vs-Stage4
8.379400E-01
Stage1-vs-Stage2
4.834200E-01
Stage1-vs-Stage3
5.351400E-01
Stage1-vs-Stage4
6.978400E-01
Stage2-vs-Stage3
2.920800E-01
Stage2-vs-Stage4
8.408400E-01
Stage3-vs-Stage4
3.823600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.757400E-01
Normal-vs-AfricanAmerican
6.740800E-01
Normal-vs-Asian
5.958000E-01
Caucasian-vs-AfricanAmerican
3.786200E-01
Caucasian-vs-Asian
3.371800E-01
AfricanAmerican-vs-Asian
3.290400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.031400E-01
Normal-vs-Female
9.036600E-01
Male-vs-Female
8.950600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.633600E-01
Normal-vs-Age(41-60Yrs)
5.317200E-01
Normal-vs-Age(61-80Yrs)
5.796600E-01
Normal-vs-Age(81-100Yrs)
8.606200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.944810E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.077600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.185000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.68480000000337E-05
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.380030E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.845400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.764400E-01
Normal-vs-Daily Drinker
7.947800E-01
Normal-vs-Weekly Drinker
7.200000E-01
Normal-vs-Occasional Drinker
9.001600E-01
Normal-vs-Social Drinker
9.393000E-01
Non Drinker-vs-Daily Drinker
7.291000E-01
Non Drinker-vs-Weekly Drinker
7.291600E-01
Non Drinker-vs-Occasional Drinker
2.221800E-01
Non Drinker-vs-Social Drinker
2.373200E-01
Daily Drinker-vs-Weekly Drinker
9.947000E-01
Daily Drinker-vs-Occasional Drinker
4.751800E-01
Daily Drinker-vs-Social Drinker
5.344000E-01
Weekly Drinker-vs-Occasional Drinker
4.755600E-01
Weekly Drinker-vs-Social Drinker
4.772200E-01
Occasional Drinker-vs-Social Drinker
8.838800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.032200E-01
Normal-vs-Grade 2
8.385600E-01
Normal-vs-Grade 3
8.466600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.465780E-01
Grade 1-vs-Grade 3
2.120600E-01
Grade 1-vs-Grade 4
9.032200E-01
Grade 2-vs-Grade 3
8.971200E-01
Grade 2-vs-Grade 4
8.385600E-01
Grade 3-vs-Grade 4
8.466600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.098800E-01
Normal-vs-NonDiabetic
7.856400E-01
Diabetic-vs-NonDiabetic
8.579400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.210400E-01
Normal-vs-NoPancreatitis
8.305200E-01
Pancreatitis-vs-NoPancreatitis
5.194000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.363000E-01
Normal-vs-N1
9.480600E-01
N0-vs-N1
2.801900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.496200E-01
Normal-vs-TP53-NonMutant
2.022800E-01
TP53-Mutant-vs-TP53-NonMutant
3.711800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
